126 related articles for article (PubMed ID: 26506882)
41. Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy.
Lu T; Guo Q; Cui X; Chen Z; Lin S; Xu L; Lin J; Zong J; Pan J
Yonsei Med J; 2016 Jul; 57(4):840-5. PubMed ID: 27189275
[TBL] [Abstract][Full Text] [Related]
42. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
Cao X; Han Y; He L; Xiang J; Wen Z
Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
[TBL] [Abstract][Full Text] [Related]
43. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
44. [Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy].
Hu Y; Lu T; Mai W; Han F; Huang Y; Liu H; Zhang E
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):463-7. PubMed ID: 12761966
[TBL] [Abstract][Full Text] [Related]
45. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
46. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
47. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract][Full Text] [Related]
48. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
49. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
50. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
[TBL] [Abstract][Full Text] [Related]
51. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
52. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
53. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
[TBL] [Abstract][Full Text] [Related]
54. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
[TBL] [Abstract][Full Text] [Related]
55. Treatment outcome of childhood nasopharyngeal carcinoma: A single institution experience.
Nikitovic M; Popovic-Vukovic M; Stanic D; Bokun J; Paripovic L; Ilic V; Miskovic I; Saric M
Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():168-172. PubMed ID: 30173978
[TBL] [Abstract][Full Text] [Related]
56. [Clinical and prognostic analysis of nasopharyngeal carcinoma in 44 children and adolescents].
Hong JD; Liao YP; Yuan J; Wei R; Wang XW; Mao HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):723-6. PubMed ID: 18772513
[TBL] [Abstract][Full Text] [Related]
57. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
[TBL] [Abstract][Full Text] [Related]
58. Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.
Guo Q; Lu T; Lin S; Zong J; Chen Z; Cui X; Zhang Y; Pan J
Jpn J Clin Oncol; 2016 Mar; 46(3):241-7. PubMed ID: 26755831
[TBL] [Abstract][Full Text] [Related]
59. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
[TBL] [Abstract][Full Text] [Related]
60. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
